Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

  • Scientific challenges facing the TB vaccine field
  • Next Generation TB Vaccines and Vaccine Concepts
  • TB vaccine development

Related Conference of Tuberculosis Vaccines

August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand
October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia
November 14-15, 2019

2nd International Conference on Vaccine Research

Geneva, Switzerland
November 21-22, 2019

International conference on Vaccine and Vaccine research

Berlin,Germany

Tuberculosis Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in